Najla Guthrie

“We are not going to be walking into a dispensary and buying DMT or ayahuasca any time soon,” said Simeon Schnapper, managing partner JLS FUND at Benzinga Psychedelics Capital Conference Thursday in Miami Beach, Florida. Comparing the cannabis and psychedelics...

In its capacity as a financial news and media outlet, Benzinga has added six new members to its Psychedelics Advisory Council. The new members include renowned author Amanda Siebert; Revitalist Lifestyle & Wellness (OTCMKTS: RVLWF) CEO Kathryn Walker; Inbodied Life...

Wellbeing Digital Sciences Inc. (OTCQB: KONEF) (NEO:MEDI) (FRA:SQ2), has entered into a definitive agreement under which Pathway Health Corp. will acquire all or substantially all of the operating assets of Wellbeing’s subsidiary IRP Health Ltd. Under the transaction, Pathway would acquire...

Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses. Numbers for the selected period showed: Total revenue of $872.731 (CA$1,160,547), representing a 2.5% increase compared to...

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape. To that end, the board is comprised by the leading minds and voices in the space, who share...

KGK Sciences Inc., a subsidiary company of psychedelics healthcare researcher and provider Wellbeing Digital Sciences Inc. (OTC: KONEF), has entered into a research services agreement with Halucenex Life Sciences Inc., a psychedelics subsidiary of Creso Pharma (OTC: COPHF) developing phase 2...

Mental healthcare company Wellbeing Digital Sciences Inc. (OTC: KONEF) and its subsidiary KGK Science Inc. are the founding sponsors of the Women in Psychedelics Network, also known as “WIP.”  The new project is founded and led by Wellbeing’s CEO Najla Guthrie, and it aims to...

Auxly Cannabis Group Inc. (OTCQX: CBWTF) announced Thursday that it's selling KGK Science Inc. to Myconic Capital Corp. (NEO: MEDI). The Vancouver-based investment company agreed to purchase KGK for up to $16.5 million. Transaction Details: The sum Myconic has agreed to pay includes $12.5...